NDRA NASDAQ
ENDRA Life Sciences Inc.
1W: +0.3%
1M: -6.2%
3M: +26.5%
YTD: +41.3%
1Y: +5.4%
3Y: -99.7%
5Y: -100.0%
$6.06
+0.18 (+3.06%)
Weekly Expected Move ±11.2%
$5
$5
$6
$7
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
8 relationships8
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-06-21
Earliest Filing
2025-10-30
Latest Filing
partner: 8
Counterparties (Filed by NDRA)
8 relationshipsCompanies named in NDRA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Lucid Capital Markets, LLC | LCID | partner | Sales agent for At-The-Market Issuance Sales Agreement | 2025-10-30 | View |
| Arca Investment Management, LLC | — | partner | Asset management partner for the Company's digital asset treasury strategy | 2025-10-15 | View |
| Anchorage Digital Bank, N.A. | — | partner | Custodian for the Company's digital asset treasury holdings | 2025-10-15 | View |
| Ascendiant Capital Markets, LLC | — | partner | Sales agent for the terminated At-The-Market Issuance Agreement | 2025-10-15 | View |
| Craig-Hallum Capital Group LLC | — | partner | Placement agent for the issuance and sale of common stock and warrants | 2024-06-06 | View |
| VStock Transfer, LLC | — | partner | Warrant agent for the warrants issued in the offering | 2023-05-02 | View |
| General Electric Company | GE | partner | Amendment to Collaborative Research Agreement extending term to December 16, 2024 | 2022-12-19 | View |
| Ascendiant Capital Markets, LLC | — | partner | Entered into an At-The-Market Issuance Sales Agreement to act as sales agent for the Company's common stock offerings. | 2021-06-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-01 | Material Agreement; Exhibits | Agreement | View |
| 2026-08-17 | Earnings Release; Exhibits | View | |
| 2026-07-09 | Other Events | View | |
| 2026-06-26 | Material Agreement; Change in Control; Regulation FD; Other Events; Exhibits | Agreement | View |
| 2026-06-25 | Regulation FD; Exhibits | View | |
| 2026-05-28 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-04-21 | Delisting Notice | View | |
| 2026-03-31 | Earnings Release; Exhibits | View | |
| 2026-03-25 | Exit/Disposal Costs; Regulation FD; Exhibits | View | |
| 2025-12-15 | Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or | View | |
| 2025-11-28 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-14 | Other Events | View | |
| 2025-10-30 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-10-23 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-15 | Financial Statements and Exhibits | View | |
| 2025-10-15 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Unregistered | Agreement | View |
| 2025-07-23 | Other Events | View | |
| 2025-07-09 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-11 | Regulation FD Disclosure | View | |
| 2025-05-30 | Notice of Delisting or Transfer | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR